Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer.

Autor:	Jonker, D J1, Karapetis, C S2, Harbison, C3, O'Callaghan, C J4, Tu, D4, Simes, R J5, Malone, D P3, Langer, C6, Tebbutt, N7, Price, T J8, Shapiro, J9, Siu, L L10, Wong, R P W11, Bjarnason, G12, Moore, M J10, Zalcberg, J R13, Khambata-Ford, S3
Zdroj:	British Journal of Cancer. 2/4/2014, Vol. 110 Issue 3, p648-655. 8p. 1 Diagram, 2 Charts, 2 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu